Ind Swift Laboratories

Rediff.com » News » Ind Swift Laboratories

News for Ind Swift Laboratories

Business

Ind Swift closes buyback

Ind-Swift Ltd completed buyback of 25,56,600 shares constituting 23.14% stake held by Punjab State Industrial Development Corporation in its sister company Ind-Swift Laboratories Ltd for Rs 82......

Ind-Swift Lab to issue shares

Ind-Swift Laboratories Ltd okayed preferential issue of 40,00,000 shares.BSE code:...

Ind Swift Lab re-issues shares

Ind Swift Laboratories Ltd re-issued 1,75,900 shares, which were earlier forfeited by the company due to non-payment of allotment/call money.BSE Code:...

Indian drug majors to supply life-saving medicines to Iran

Major drug makers from India such as Ranbaxy, Cipla, Glenmark and Ind-Swift Laboratories will supply life-saving drugs to the Islamic Republic of Iran."Iran, faced with a shortage of life-saving......

Chinese drugs pose threat to Indian pharma

Cheap bulk drug imports from China may soon post a threat to the Rs 20,000 crore (Rs 200 billion) domestic bulk drug industry. Indian companies are finding it impossible to arrest the trend as the......

Rediffmail for WorkBook a domainRediffmailMoneyOnline ShoppingVideos

Ind Swift Laboratories

News for Ind Swift Laboratories

Ind Swift closes buyback

Ind-Swift Lab to issue shares

Ind Swift Lab re-issues shares

Indian drug majors to supply life-saving medicines to Iran

Chinese drugs pose threat to Indian pharma

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS